论文信息 - The immune system likes nanotechnology. - 字舞流文

The immune system likes nanotechnology.

Istvan Toth | Mariusz Skwarczynski | M. Skwarczynski | I. Toth

[1] M. Amiji,et al. The impact of size on particulate vaccine adjuvants. , 2014, Nanomedicine.

[2] B. Verrier,et al. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery. , 2014, Nanomedicine.

[3] M. Skwarczynski,et al. Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity. , 2014, Nanomedicine.

[4] Istvan Toth,et al. Recent advances in peptide-based subunit nanovaccines. , 2014, Nanomedicine.

[5] Liana C. Silva,et al. Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach. , 2014, Nanomedicine.

[6] C. Foged,et al. A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell response. , 2014, Nanomedicine.

[7] Felipe García,et al. Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation. , 2014, Nanomedicine.